📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Ambrx

1.1 - Company Overview

Ambrx Logo

Ambrx

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of an expanded genetic code technology platform to discover and develop Engineered Precision Biologics, including next-generation ADCs, bispecific antibodies, targeted immuno-oncology therapies, novel cytokines and long-acting therapeutics; with clinical programs ARX788 for HER2-positive breast cancer and ARX517 for advanced prostate cancer, and partnerships to advance ADC oncology programs.

Products and services

  • Expanded Genetic Code Technology Platform: Custom-engineered technology incorporating synthetic amino acids into proteins for site-specific conjugation, enhancing biologic drug stability and efficacy and enabling ADCs, bispecifics, targeted immuno-oncology therapies, novel cytokines, and long-acting therapeutics
  • ARX788: Site-specific antibody-drug conjugate targeting HER2-positive breast cancer, currently in clinical development, architected for precise conjugation and targeted HER2 engagement in oncology applications
  • ARX517: Clinical-stage antibody-drug conjugate targeting PSMA for the treatment of advanced prostate cancer, under clinical evaluation, engineered to deliver PSMA-directed therapy within ADC oncology programs

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Ambrx

Transgenomic Logo

Transgenomic

HQ: United States Website
  • Description: Provider of nucleic acid purification and analysis products for life sciences research.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Transgenomic company profile →
Vanadis Diagnostics Logo

Vanadis Diagnostics

HQ: Sweden Website
  • Description: Provider of a novel non-invasive prenatal testing (NIPT) solution in development based on digital analysis of cell-free DNA.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Vanadis Diagnostics company profile →
Basepaws Logo

Basepaws

HQ: United States Website
  • Description: Provider of at-home genetic testing for cats and dogs, including cat and dog DNA tests for breed analysis, trait information, and health risk markers; cat oral microbiome tests to screen for dental diseases; and whole genome sequencing for cats providing extensive genome data on health, traits, and breed.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Basepaws company profile →
Mirati Therapeutics Logo

Mirati Therapeutics

HQ: United States Website
  • Description: Provider of biotechnology, based at 9363 Towne Centre Dr, San Diego, CA, United States.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Mirati Therapeutics company profile →
Onkaido Therapeutics Logo

Onkaido Therapeutics

HQ: United States Website
  • Description: Provider of research into messenger RNA therapeutics aimed at delivering novel oncology drugs to help patients.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Onkaido Therapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Ambrx

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Ambrx

2.2 - Growth funds investing in similar companies to Ambrx

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Ambrx

4.2 - Public trading comparable groups for Ambrx

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Ambrx

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Ambrx

What does Ambrx do?

Ambrx is a provider of an expanded genetic code technology platform to discover and develop Engineered Precision Biologics, including next-generation ADCs, bispecific antibodies, targeted immuno-oncology therapies, novel cytokines and long-acting therapeutics; with clinical programs ARX788 for HER2-positive breast cancer and ARX517 for advanced prostate cancer, and partnerships to advance ADC oncology programs.

Who are Ambrx's competitors?

Ambrx's competitors and similar companies include Transgenomic, Vanadis Diagnostics, Basepaws, Mirati Therapeutics, and Onkaido Therapeutics.

Where is Ambrx headquartered?

Ambrx is headquartered in United States.

How many employees does Ambrx have?

Ambrx has 1,000 employees 🔒.

When was Ambrx founded?

Ambrx was founded in 2010 🔒.

What sector and industry vertical is Ambrx in?

Ambrx is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Ambrx

Who are the top strategic acquirers in Ambrx's sector and industry

Top strategic M&A buyers and acquirers in Ambrx's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Ambrx?

Top strategic M&A buyers groups and sectors for Ambrx include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Ambrx's sector and industry vertical

Which are the top PE firms investing in Ambrx's sector and industry vertical?

Top PE firms investing in Ambrx's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Ambrx's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Ambrx's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Ambrx's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Ambrx include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Ambrx's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Ambrx?

The key public trading comparables and valuation benchmarks for Ambrx include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Ambrx for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Ambrx with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Ambrx's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Ambrx with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Ambrx's' sector and industry vertical?

Access recent funding rounds and capital raises in Ambrx's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Ambrx

Launch login modal Launch register modal